REG - Barclays PLC Quanex Building Prod - Form 8.3 - QUANEX BUILDING PRODUCTS CORP
01/08/2024 15:15
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240801:nRSA8649Ya&default-theme=true
RNS Number : 8649Y Barclays PLC 01 August 2024
FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
Rule 8.3 of the Takeover Code (the "Code")
1. KEY INFORMATION
(a) Full name of discloser: Barclays PLC.
(b) Owner or controller of interest and short
positions disclosed, if different from 1(a):
(c) Name of offeror/offeree in relation to whose QUANEX BUILDING PRODUCTS CORP
relevant securities this form relates:
(d) If an exempt fund manager connected with an
offeror/offeree, state this and specify identity of
offeror/offeree:
(e) Date position held/dealing undertaken: 31 Jul 2024
(f) In addition to the company in 1(c) above, is the discloser making YES:
disclosures in respect of any other party to the offer? TYMAN PLC
2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE
(a) Interests and short positions in the relevant securities of the offeror or
offeree
to which the disclosure relates following the dealing(if any)
Class of relevant security: Common
Interests Short Positions
Number (%) Number (%)
(1) Relevant securities owned
and/or controlled: 74,637 0.23% 44,029 0.13%
(2) Cash-settled derivatives:
and/or controlled: 38,140 0.12% 0 0.00%
(3) Stock-settled derivatives (including options)
and agreements to purchase/sell: 0 0.00% 0 0.00%
TOTAL: 112,777 0.34% 44,029 0.13%
(b) Rights to subscribe for new securities (including directors and other
executive
options)
Class of relevant security in relation to
which subscription right exists
Details, including nature of the rights
concerned and relevant percentages:
3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER
(a) Purchases and sales
Class of relevant Purchase/sale Number of Price per unit
security securities
Common Purchase 419,760 33.4000 USD
Common Purchase 269,352 33.4427 USD
Common Purchase 153,411 33.3990 USD
Common Purchase 12,352 33.5591 USD
Common Purchase 4,127 33.6705 USD
Common Purchase 3,733 33.1664 USD
Common Purchase 3,000 32.7247 USD
Common Purchase 2,668 33.2844 USD
Common Purchase 2,000 33.5457 USD
Common Purchase 644 33.2682 USD
Common Purchase 629 33.0572 USD
Common Purchase 400 33.5800 USD
Common Purchase 290 33.4823 USD
Common Purchase 257 33.3956 USD
Common Purchase 200 33.5600 USD
Common Purchase 180 33.3991 USD
Common Purchase 108 33.5630 USD
Common Purchase 105 33.4919 USD
Common Purchase 85 33.3120 USD
Common Purchase 70 33.4821 USD
Common Purchase 70 33.3940 USD
Common Purchase 28 34.0300 USD
Common Purchase 17 33.8147 USD
Common Purchase 15 33.5066 USD
Common Purchase 15 33.4633 USD
Common Purchase 10 33.4325 USD
Common Purchase 5 33.4300 USD
Common Purchase 1 33.3000 USD
Common Sale 286,291 33.4000 USD
Common Sale 270,317 33.3990 USD
Common Sale 168,841 33.4158 USD
Common Sale 24,910 33.4075 USD
Common Sale 24,458 33.5026 USD
Common Sale 14,410 33.5442 USD
Common Sale 11,546 33.4698 USD
Common Sale 11,239 33.5661 USD
Common Sale 7,950 33.5027 USD
Common Sale 5,274 33.6551 USD
Common Sale 4,838 33.5014 USD
Common Sale 4,440 33.1267 USD
Common Sale 4,282 33.6608 USD
Common Sale 3,220 33.4159 USD
Common Sale 3,000 32.7247 USD
Common Sale 2,009 33.5710 USD
Common Sale 2,000 33.5457 USD
Common Sale 1,378 33.4919 USD
Common Sale 1,201 33.3984 USD
Common Sale 818 33.4453 USD
Common Sale 674 33.5323 USD
Common Sale 629 33.0572 USD
Common Sale 500 33.5530 USD
Common Sale 409 33.0360 USD
Common Sale 400 33.3850 USD
Common Sale 349 33.4822 USD
Common Sale 324 33.2832 USD
Common Sale 200 33.4325 USD
Common Sale 200 33.6950 USD
Common Sale 200 33.5600 USD
Common Sale 180 33.3991 USD
Common Sale 133 33.4718 USD
Common Sale 120 33.6639 USD
Common Sale 100 34.0000 USD
Common Sale 100 33.5700 USD
Common Sale 90 33.9200 USD
Common Sale 66 33.3703 USD
Common Sale 58 33.7137 USD
Common Sale 57 33.5484 USD
Common Sale 50 33.0600 USD
Common Sale 14 33.9600 USD
Common Sale 12 33.4350 USD
Common Sale 8 33.4762 USD
Common Sale 5 33.4300 USD
Common Sale 4 33.7850 USD
(b) Cash-settled derivative transactions
Class of Product Nature of dealing Number of Price per
relevant description reference unit
security securities
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
Class Product Writing, Number Exercise Type Expiry Option
of description purchasing, of price date money
relevant selling, securities per unit paid/
security varying etc to which received
option per unit
relates
(ii) Exercising
Class of relevant Product description Exercising/ exercised against Number of Exercise price per
security securities unit
(d) Other dealings (including subscribing for new securities)
Class of relevant Nature of Dealings Details Price per unit (if
security applicable)
4. OTHER INFORMATION
(a) Indemnity and other dealings arrangements
Details of any indemnity or option arrangement, or any agreement or
understanding,
formal or informal, relating to relevant securities which may be an inducement
to deal
or refrain from dealing entered into by the exempt principal trader making the
disclosure and any party
to the offer or any person acting in concert with a party to the offer:
NONE
(b) Agreements, arrangements or understandings relating to options or derivatives
Details of any agreement, arrangement or understanding, formal or informal,
between
the person making the disclosure and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights of future acquisition or disposal of any relevant
securities to which
any derivative is referenced:
NONE
(c) Attachments
Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 01 Aug 2024
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END RETQKDBKQBKDAFKRecent news on Quanex Building Products
See all newsREG - AllianceBernstein LP Tyman PLC - Form 8.3 - Tyman PLC
AnnouncementREG - AllianceBernstein LP Quanex Building Prod - Form 8.3 - Quanex Building Products Corp
AnnouncementREG - Syquant Capital Quanex Building Prod Tyman PLC - Form 8.3 - Quanex Building Products Corp
AnnouncementREG - BlackRock Group Quanex Building Prod - Form 8.3 - Quanex Building Products Corporation
AnnouncementREG - Barclays PLC Quanex Building Prod - Form 8.3 - QUANEX BUILDING PRODUCTS CORP
Announcement